Adrienne M. Hammill

4.1k total citations · 1 hit paper
62 papers, 1.6k citations indexed

About

Adrienne M. Hammill is a scholar working on Surgery, Neurology and Oncology. According to data from OpenAlex, Adrienne M. Hammill has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Surgery, 18 papers in Neurology and 18 papers in Oncology. Recurrent topics in Adrienne M. Hammill's work include Vascular Malformations and Hemangiomas (48 papers), Tumors and Oncological Cases (17 papers) and Vascular Tumors and Angiosarcomas (16 papers). Adrienne M. Hammill is often cited by papers focused on Vascular Malformations and Hemangiomas (48 papers), Tumors and Oncological Cases (17 papers) and Vascular Tumors and Angiosarcomas (16 papers). Adrienne M. Hammill collaborates with scholars based in United States, Canada and France. Adrienne M. Hammill's co-authors include Denise M. Adams, Roshni Dasgupta, Richard H. Scheuermann, Jonathan W. Uhr, Anita Gupta, Stephen C. Nelson, Richard G. Azizkhan, Anne W. Lucky, Paula S. Mobberley‐Schuman and Alexander A. Vinks and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Adrienne M. Hammill

59 papers receiving 1.6k citations

Hit Papers

Sirolimus for the treatment of complicated vascular anoma... 2011 2026 2016 2021 2011 100 200 300 400

Peers

Adrienne M. Hammill
Adam Mizeracki United States
Byung-Boong Lee South Korea
Daniel Chubb Australia
Richard Chang United States
Adam Mizeracki United States
Adrienne M. Hammill
Citations per year, relative to Adrienne M. Hammill Adrienne M. Hammill (= 1×) peers Adam Mizeracki

Countries citing papers authored by Adrienne M. Hammill

Since Specialization
Citations

This map shows the geographic impact of Adrienne M. Hammill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrienne M. Hammill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrienne M. Hammill more than expected).

Fields of papers citing papers by Adrienne M. Hammill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrienne M. Hammill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrienne M. Hammill. The network helps show where Adrienne M. Hammill may publish in the future.

Co-authorship network of co-authors of Adrienne M. Hammill

This figure shows the co-authorship network connecting the top 25 collaborators of Adrienne M. Hammill. A scholar is included among the top collaborators of Adrienne M. Hammill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrienne M. Hammill. Adrienne M. Hammill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eng, Whitney, Ionela Iacobas, Jonathan A. Perkins, et al.. (2025). Safety findings from the phase 1/2 MOSAIC study of miransertib for patients with PIK3CA-related overgrowth spectrum or Proteus syndrome. Orphanet Journal of Rare Diseases. 20(1). 375–375.
2.
Harmon, Kelly A., Katherine A. Kaplan, Michael D. Taylor, et al.. (2024). Longitudinal prospective study of Sturge–Weber syndrome urine angiogenic factors and neurological outcome. SHILAP Revista de lepidopterología. 2(2). 120–134. 1 indexed citations
3.
Beslow, Lauren A., Timo Krings, Adrienne M. Hammill, et al.. (2024). Current Practice: Rationale for Screening Children with Hereditary Hemorrhagic Telangiectasia for Brain Vascular Malformations. American Journal of Neuroradiology. 45(9). 1177–1184. 2 indexed citations
4.
Canaud, Guillaume, et al.. (2024). Epik-P2: A Phase 2 Study of Alpelisib (ALP) in Pediatric and Adult Patients (pts) with PIK3CA-Related Overgrowth Spectrum (PROS). Blood. 144(Supplement 1). 5512–5512. 1 indexed citations
5.
Cohen, Bernard A., Clifford R. Weiss, Carolina Montaño, et al.. (2023). Genetic testing in the evaluation of individuals with clinical diagnosis of atypicalSturge–Webersyndrome. American Journal of Medical Genetics Part A. 191(4). 983–994. 4 indexed citations
6.
Ola, Roxana, Adrienne M. Hammill, Marianne S. Clancy, et al.. (2023). Executive summary of the 14th HHT international scientific conference. Angiogenesis. 26(S1). 27–37. 6 indexed citations
7.
Blatt, Julie, et al.. (2023). Vascular Anomalies Care in the United States: A Cross-Sectional National Survey. The Journal of Pediatrics. 261. 113579–113579. 2 indexed citations
9.
Adams, Denise M., Kimberley E. Steele, Adrienne M. Hammill, et al.. (2023). Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment. Pediatric Blood & Cancer. 70(4). e30219–e30219. 18 indexed citations
10.
Hammill, Adrienne M., Denise M. Adams, Roderic J. Phillips, et al.. (2023). Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response. Pediatric Blood & Cancer. 70(4). e30215–e30215. 12 indexed citations
11.
Setty, Bhuvana A., Katie Wusik, & Adrienne M. Hammill. (2022). How we approach genetics in the diagnosis and management of vascular anomalies. Pediatric Blood & Cancer. 69(S3). e29320–e29320. 12 indexed citations
12.
Teng, Joyce, et al.. (2022). Sirolimus in the Treatment of Microcystic Lymphatic Malformations: A Systematic Review. Lymphatic Research and Biology. 21(2). 101–110. 11 indexed citations
13.
Taylor, J. Michael, Kasiani C. Myers, Thomas Andrew Burrow, et al.. (2021). Case Report: Cerebral Revascularization in a Child With Mucopolysaccharidosis Type I. Frontiers in Pediatrics. 9. 606905–606905. 1 indexed citations
14.
Hammill, Adrienne M., Csaba Juhász, Warren Lo, et al.. (2021). Multicenter Research Data of Epilepsy Management in Patients With Sturge-Weber Syndrome. Pediatric Neurology. 119. 3–10. 19 indexed citations
15.
Ewen, Joshua B., Anna W. Byars, Bernard A. Cohen, et al.. (2020). Sirolimus Treatment in Sturge-Weber Syndrome. Pediatric Neurology. 115. 29–40. 35 indexed citations
16.
Scorletti, Federico, Adrienne M. Hammill, Manish Patel, Kiersten Ricci, & Roshni Dasgupta. (2018). Malignant tumors misdiagnosed as benign vascular anomalies. Pediatric Blood & Cancer. 65(7). e27051–e27051. 6 indexed citations
17.
Adams, Denise M. & Adrienne M. Hammill. (2014). Other vascular tumors. Seminars in Pediatric Surgery. 23(4). 173–177. 22 indexed citations
18.
Hammill, Adrienne M., Anita Gupta, Stephen C. Nelson, et al.. (2011). Sirolimus for the treatment of complicated vascular anomalies in children. Pediatric Blood & Cancer. 57(6). 1018–1024. 423 indexed citations breakdown →
19.
Hsueh, Robert C., Adrienne M. Hammill, Radu Marcheş, J W Uhr, & Richard H. Scheuermann. (1999). Antigen Receptor Signaling Induces Differential Tyrosine Kinase Activation and Population Stability in B-Cell Lymphoma. Current topics in microbiology and immunology. 246. 299–305. 5 indexed citations
20.
Hammill, Adrienne M., Jonathan W. Uhr, & Richard H. Scheuermann. (1999). Annexin V Staining Due to Loss of Membrane Asymmetry Can Be Reversible and Precede Commitment to Apoptotic Death. Experimental Cell Research. 251(1). 16–21. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026